SIS
AUPH icon

Sound Income Strategies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Sound Income Strategies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-851
Closed -$13.2K – 616
2026
Q1 		$13.2K Hold
851
– – ﹤0.01% 1377
2025
Q4 		$12.6K Buy
+851
New +$12.1K ﹤0.01% 1340

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Sound Income Strategies's AUPH Position: Q2 2026 in Review

Sound Income Strategies sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 851 shares — an estimated $13.2K sold.

Sound Income Strategies first reported a position in AUPH in Q4 2025 and held it in 2 quarters. The position peaked at $13.2K in Q1 2026. 64 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Sound Income Strategies reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 851 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $13.2K.
  • Sound Income Strategies first reported a position in Aurinia Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Aurinia Pharmaceuticals position peaked at $13.2K in Q1 2026.
  • 64 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.